Blood product utilization system and methods

• US 20080147444A1
• Filed: 11/06/2007
• Published: 06/19/2008
• Est. Priority Date: 11/06/2006
• Status: Abandoned Application

• Current Assignee: David F. Jadwin, Steven L. Bennett
• Original Assignee: David F. Jadwin, Steven L. Bennett
• Inventors: Bennett, Steven L., Jadwin, David F.
• Application Number:
  US11/983,077
• Publication Number:
  US 20080147444A1
• Time in Patent Office: Days
• US Class Current: 705/3
• CPC Class Codes: G16H 10/40 for data related to laboratory analysis, e.g. patient specimen analysis
• CPC Class Codes: G16H 10/60 for patient-specific data, e.g. for electronic patient records
• CPC Class Codes: G16H 20/40 relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
• CPC Class Codes: G16H 40/20 for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
• CPC Class Codes: G16H 50/70 for mining of medical data, e.g. analysing previous cases of other patients

Abstract

A method and system is provided featuring a computer database containing select clinical observations and laboratory data for each of a number of patients in conjunction with healthcare provided such as blood product transfusion utilization for each patient. Particularly, the database is accessible remotely such as via the worldwide web. The method and system is particularly useful for review of health care provided such as the appropriateness of blood product utilization and allows patterns of utilization by individual healthcare providers or healthcare institutions to be determined on a confidential basis.

Claims

1. A method of determining whether a transfusion of a blood product to a patient is or was appropriate comprising:

(a) obtaining relevant laboratory or clinical information regarding the patient;

(b) entering the relevant laboratory or clinical information regarding the patient into a database;

(c) transmitting the relevant laboratory or clinical information regarding the patient to a clinical reviewer; and

(d) comparing the relevant laboratory or clinical information regarding the patient to established medical practice standards.

2. The method according to claim 1 wherein the relevant laboratory or clinical information is selected from the group consisting of a patient'"'"'s hemoglobin or hematocrit levels, platelet count, age, blood pressure, weight, pulse, estimated blood loss, PT, PTT, and fibrinogen levels.

3. The method according to claim 1 wherein the relevant laboratory or clinical information is obtained before transfusion with a blood product.

4. The method according to claim 1 wherein the relevant laboratory or clinical information is obtained after transfusion with a blood product.

5. The method according to claim 1 wherein the blood product is selected from the group consisting of red blood cells, platelets and fresh frozen plasma (FFP).

6. The method according to claim 1 wherein the transmitting is performed via the worldwide web.

7. A method of evaluating blood product transfusion of a healthcare provider or healthcare institution comprising

(a) obtaining utilization information stored in a computer system

(b) obtaining relevant laboratory or clinical information regarding patients receiving transfusions;

(c) correlating the amount of blood product transfused with the relevant laboratory or clinical information; and

(d) determining whether the transfusion is or was appropriate according to established medical practice standards.

8. The method according to claim 7 wherein the relevant laboratory or clinical information is selected from the group consisting of a patient'"'"'s hemoglobin or hematocrit levels, platelet count, age, blood pressure, weight, pulse, estimated blood loss, PT, PTT, and fibrinogen levels.

9. The method according to claim 7 wherein the relevant laboratory or clinical information is obtained before transfusion with a blood product.

10. The method according to claim 7 wherein the relevant laboratory or clinical information is obtained after transfusion with a blood product.

11. The method according to claim 7 wherein the blood product is selected from the group consisting of red blood cells, platelets and fresh frozen plasma (FFP).

12. The method according to claim 7 wherein the obtaining is performed via the worldwide web.

13. A programmable computer system for use in determining whether transfusion with a blood product is or was appropriate, comprising a central processing unit, a system memory, a display device, an input device, and a control device, wherein said central processing unit is enabled with a software application capable of generating a display of medical data, said central processing unit further comprising an operating system capable of interfacing with said software application, said system memory capable of storing data in user-defined, sortable databases, said control device capable of directing activity of said software application.

14. The system of claim 13, wherein said software application is capable of assigning a clinical score in response to one or more relevant laboratory or clinical information data and wherein said clinical score is indicative of the degree transfusion with a blood product is or was warranted.

15. The system of claim 13, wherein said operating system is selected from the group comprising Macintosh, DOS, Windows, Windows NT, OS/2, OS/3, and Unix.

16. The system of claim 13, wherein said input device is selected from the group consisting of a keyboard, bar code reader, touch screen, scanner, voice recognition and combinations thereof.

17. The system of claim 13, wherein said system memory is a system hard drive.

18. The computer system of claim 13, wherein said auxiliary memory is selected from the group comprising a floppy disk, CD Rom, Internet server memory storage device, network drive, or server.

19. A medical information database in a programmable computer system for use in tracking transfusion activity wherein the medical information database is accessible by at least one external reviewer via the worldwide web.

20. An improved patient medical information database for use in evaluating blood product transfusion of a healthcare provider or a healthcare institution, wherein the improvement comprises a communication link whereby the information database is accessible to a clinical reviewer remotely or via the worldwide web.

21. An improved patient medical information database for use in evaluating blood product transfusion of a healthcare provider or a healthcare institution, wherein the improvement comprises a three tier process applied to the patient medical records so that patient, physician and hospital information is masked prior to processing by external utilization and evaluation by peer reviewers.

22. An improved patient medical information database for use in evaluating blood product transfusion of a healthcare provider or a healthcare institution, wherein the improvement comprises the application of black opaque masks and the application of red opaque masks to patient medical records followed by the routing of the masked medical records via the Internet to external reviewers while the confidentiality of the patient, the physician and the healthcare facility is maintained.